American Marconi Wireless News - News from Boston, Massachusetts, the USA and the world, around the clock every day

ELEKTROS Inc. - Publicly Traded (Ticker Symbol: ELEK)

Dr. Louis DeJoseph reviews who may benefit from a neck lift and why surgeon credentials, aesthetic style, and realistic expectations matter when considering treatment.

LUBBOCK, TX / ACCESS Newswire / August 13, 2026 / Glo Tanning announces the opening of its newest location in Lubbock, Texas, on August 8, bringing its signature blend of skincare, wellness, and tanning services to the community.

ELEKTROS Inc. - Publicly Traded (Ticker Symbol: ELEK)

WEST PALM BEACH, FL / ACCESS Newswire / August 13, 2026 / ELEKTROS Inc. (OTC PINK:ELEK) today underscored its long-term hard-rock lithium and EV charging strategy against the backdrop of resilient U.S. markets and a rapidly evolving technology-driven economy. Management believes the extraordinary scale of investment flowing into artificial intelligence, data centers, electrification and advanced infrastructure represents a distinctive and potentially transformative moment for the American economy and, by extension, the broader global marketplace.

US$500,000 FNGR Share Consideration Implies Approximately US$5M Lyken Equity Value Based on Transaction Price

TORONTO, ON / ACCESS Newswire / August 13, 2026 / If you've taken even a casual glance at local real estate headlines lately, you already know the story: soaring holding costs, unpredictable interest rate shifts, longer days on market, and buyers taking their sweet time to make an offer. For homeowners across the Greater Toronto Area and major urban hubs in Alberta, selling a home through traditional channels can feel like an exhausting test of endurance.

RICHMOND, VA / ACCESS Newswire / August 13, 2026 / OT Advisors LLC, the investment sub-adviser to the Opportunistic Trader ETF (Ticker: WZRD) (the "Fund"), today announced the execution of a reverse share split of the Fund.

NEW YORK, NY / ACCESS Newswire / August 13, 2026 / Grassi, a leading employee-owned advisory, tax and accounting firm, announced today that Hoffman Mulligan has joined the firm, strengthening its high-net-worth and tax practice capabilities and expanding its presence in New York City.

Chuck Henrich, Owner and President of Southwest Michigan Financial, LLC discusses how to build a solid retirement income plan.

ST. PETERSBURG, FL / ACCESS Newswire / August 13, 2026 / Allelo, the acclaimed Mediterranean-inspired wine bar and restaurant in downtown St. Petersburg, has been named No. 5 Best Wine Bar in the United States in the 2026 USA TODAY 10Best Readers' Choice Awards.

Potential Fourth-Quarter 2026 Decision Could Mark Entolimod's First National Registration and Open a Pathway to Strategic Stockpiling and Government ProcurementFormal review accepted July 22 • Ministry begins technical assessment • Regulatory requirements defined • Potential decision as early as Q4 2026Near-Term Regulatory CatalystFormal review underway: Ukraine's Ministry of Health accepted the Entolimod dossier for formal review on July 22, 2026.Technical assessment underway: Ukraine's Ministry of Health has begun technical assessment of the dossier and issued its first round of questions, relating to the physicochemical characterization of the drug product that would be supplied under a potential stockpiling arrangement.Defined pathway: The Company has identified the analytical testing, quality-control validation, GMP verification, import-documentation, and Ukrainian-language labeling requirements applicable to the registration process.Potential Q4 decision: Valion Bio believes a regulatory decision could occur as early as the fourth quarter of 2026; there can be no assurance regarding timing or outcome.First potential national registration: A favorable decision would represent Entolimod's first national registration.Potential government-market pathway: Registration could establish a pathway toward possible inclusion in Ukraine's national strategic reserves and future government procurement. No procurement, purchase, or stockpiling agreement has been executed.

Fully human dual-antagonist bispecific antibody discovered and engineered at AlivaMab Biologics

Proprietary AI Vision Platform Delivers Rapid Strain Identification and Quality Verification Tools for Licensed Multi-Location Dispensary Operators

Dataset expands by approximately 265 million data points since July 21 as continued AI Nose system deployment across semiconductor manufacturing environments accelerates Ainos' Real-World Data Flywheel and Chemical Intelligence development

The Miami Beach practice offers the same EMSculpt NEO platform recently added to a professional football team's recovery program, including its functional health and rehabilitation protocols.

Industry leaders will address a variety of subjects, including the responsible adoption of AI in financial services and how best to scale it

Integrated national campaign to feature long-form executive interviews, earned media, television commercials, outdoor billboards and accredited investor events

Accomplished life sciences executive brings more than 20 years' experience of CDMO and pharmaceutical leadership to guide Life Sciences division

Behavioral engagement technology carries documented institutional lineage spanning Oxford, the University of Vermont, Cornell, AMCP, and a Sanofi pilot program, as inventor Dr. Chris A. Jones joins AimwellBio's Board of Advisors and leads further expansion.

Microtec UTM 1200 Turbo Mill in Transit to Myakka City for Second-Half 2026 Commissioning; Land Clearing Division Launched with First Purchase Order; Two Primary Operating Segments Delivering Sequential Revenue Growth

KELOWNA, BC / ACCESS Newswire / August 13, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has entered into a Material Transfer Agreement ("MTA") with Pegbio Co., Ltd ("PegBio") to investigate Lexaria's DehydraTECH technology with a proprietary PegBio molecule under development for the GLP-1 industry. Today's announcement is separate from, and has no relationship with, Lexaria's pre-existing Material Transfer Agreement with another pharmaceutical company.

Second quarter Net loss narrowed 35% year-over-year to approximately $2.50 millionCash and restricted cash totaled approximately $8.88 million at June 30, 2026, more than three times the $2.75 million held at December 31, 2025Convertible notes payable reduced 92% since year-end, from approximately $8.20 million to approximately $0.67 million, substantially simplifying the capital structureTotal stockholders' equity increased 163% since year-end to approximately $9.95 million; total liabilities-to-equity ratio improved from 3.12x to 0.41xInitial GPU cluster deployment underway as the Company advances toward its first AI compute revenueNamed winner of the 2026 EdTechX Award for the Americas

Advanced Seam welding and Cleanroom Systems to Be Fully Operational in Q4 2026

Company outlines adjustments to public float, lender lock-up and leak-out agreements, and growth-funding structure.

Special Purpose Vehicle to Be Formed in Connection With Proposed Transaction

NEW YORK, NY / ACCESS Newswire / August 13, 2026 / Phomemo, a global creative printing brand specializing in thermal printing solutions, has expanded its tattoo stencil printer lineup with two new solutions - the Phomemo TA81 Large-Format Tattoo Stencil Printer and Phomemo L85 Smart Touchscreen Tattoo Stencil Printer - designed to support the evolving needs of professional tattoo artists.

AI-powered career transition platform recognized for combining labor market insights, human coaching, and job search tools in one system. Users in LHH's Career Transition program find new roles 32 days faster with the platform.

ESTERO, FL / ACCESS Newswire / August 13, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced that management will be present and host one-on-one meetings with investors at Sidoti & Company's Micro-Cap Virtual Investor Conference taking place on August 19-20, 2026.

The DoD Success Memo enables government contracting officers to rapidly procure goods and services across all Federal agencies, accelerating deployment of 374Water's AirSCWO technology into the large and growing Federal marketplace.

Senior strategic hire strengthens GameSquare's regional capabilities as the Company expands its award-winning agency platform across key global markets

Core + Strategic growth program expands Ondas' technology and customer-solutions portfolio, broadens its customer base, and accelerates the maturation and scale of its operating platformRecord Q2 2026 revenue of $83.8 million marks 67% QoQ increase and 13-fold YoY revenue growth; On a pro forma, same-portfolio basis, Q2 2026 YoY revenue increased 85%$175 million in new orders were captured during Q2 2026, demonstrating the strength and momentum of the core platform; $105 million in additional orders have been captured to date during Q3 2026Reported backlog of approximately $613 million as of June 30, 2026; Pro forma backlog of $757 million as of June 30, 2026, including the DZYNE and Cyberhawk acquisitions, both of which closed in Q3 2026Increased full-year 2026 revenue target to $525 - $550 million; Pulls forward Adjusted EBITDA profitability timelines$1.4 billion in cash, cash equivalents, restricted cash and short-term investments as of June 30, 2026Conference call scheduled for today, August 13th at 8:30 a.m. ET